ViiV Healthcare UK Ltd

Stockley Park West, Uxbridge, Middlesex,, UB11 1BT, UK
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328

Patient Information Leaflet last updated on the eMC: 08/06/2011
PIL Telzir 700 mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 08/06/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 13/05/2011 and displayed until 08/06/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to drug interactions
Updated on 26/04/2011 and displayed until 13/05/2011
Reasons for adding or updating:
  • Change of manufacturer
Updated on 31/03/2011 and displayed until 26/04/2011
Reasons for adding or updating:
  • Change to drug interactions
Updated on 14/09/2010 and displayed until 31/03/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to MA holder contact details
Updated on 30/06/2010 and displayed until 14/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
Updated on 20/05/2010 and displayed until 30/06/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 09/02/2010 and displayed until 20/05/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 09/06/2009 and displayed until 09/02/2010
Reasons for adding or updating:
  • Change to date of revision
Updated on 01/04/2009 and displayed until 09/06/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to dosage and administration
Updated on 17/02/2009 and displayed until 01/04/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 06/02/2009 and displayed until 17/02/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
Updated on 08/08/2008 and displayed until 06/02/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 19/06/2008 and displayed until 08/08/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
  • Change due to user-testing of patient information
Updated on 19/01/2008 and displayed until 19/06/2008
Reasons for adding or updating:
  • Change of contra-indications
  • Change to date of revision
Updated on 26/10/2007 and displayed until 19/01/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change of contra-indications
  • Change to warnings or special precautions for use
  • Change to date of revision
  • Change to how to administer the medicine
  • Change to dosage and administration
Updated on 27/03/2007 and displayed until 26/10/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to Further Information section
  • Change to date of revision
Updated on 17/01/2007 and displayed until 27/03/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 18/05/2006 and displayed until 17/01/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to date of revision
  • Change to how to administer the medicine
Updated on 27/02/2006 and displayed until 18/05/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 30/06/2005 and displayed until 27/02/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 22/07/2004 and displayed until 30/06/2005
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   fosamprenavir calcium